glp-1 and parkinson's disease drug may help with disease, study reports GLP-1 Agonists: A New Frontier

Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, et al

Tng cng cc bin php bo v da nh che chn bng m nn, chng nng cng nh dng kem chng nng mi ngy trnh lm tn thng da

Conclusion: MT shows promise as an adjunctive intervention in managing acute cerebrovascular diseases, complementing established rehabilitation therapies

If less than 3% body weight has been lost, the prescriber either titrates higher or discontinues

Late-onset hypogonadism and mortality in aging men

And in 2023, Eli Lilly acquired Versanis for their drug candidate bimagrumab, a monoclonal antibody that appears to be effective in preserving muscle mass during weight loss